Does Rallies show SNDX 10-K and 10-Q filings?

Rallies organizes SNDX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is SNDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SNDX. It does not provide personalized investment advice.

SNDX (Syndax Pharmaceuticals, Inc.) Stock Analysis - SEC Filings

Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of May 21, 2026, SNDX trades at $19.62 with a market cap of $1.72B and a P/E ratio of -6.10. SNDX moved +4.08% today. Year to date, SNDX is -0.45%; over the trailing twelve months it is +90.44%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $39.91. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SNDX SEC filings?

Rallies organizes SNDX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SNDX Key Metrics

Key financial metrics for SNDX
Metric	Value
Price	$19.62
Market Cap	$1.72B
P/E Ratio	-6.10
EPS	$-3.29
Dividend Yield	0.00%
52-Week High	$25.59
52-Week Low	$8.58
Volume	729
Avg Volume	0
Revenue (TTM)	$172.35M
Net Income	$-285.42M
Gross Margin	0.00%

Latest SNDX News

Syndax Highlights 12 Revuforj Abstracts Accepted for EHA 2026 — May 12, 2026
Syndax Q1 Revenue $64.9M, 50% Transplant Rate Delays Maintenance Restarts — May 1, 2026
Syndax Q1 Revenue Soars 224% to $64.9M, Revuforj Hits $48.9M — Apr 30, 2026
Syndax’s Revuforj Q4 Revenue Jumps 38% to $44.2M, 1,050 Patients Treated — Feb 27, 2026
Syndax Posts $68.7M Q4, $172.4M FY25 Revenue; Revuforj Up 38%, Niktimvo Up 22% — Feb 26, 2026

Recent SNDX Insider Trades

Metzger Michael A sold 17.16K (~$360.82K) on Feb 9, 2026.
Goldan Keith A. sold 3.41K (~$71.71K) on Feb 9, 2026.
Metzger Michael A sold 7.41K (~$152.84K) on Feb 6, 2026.

SNDX Analyst Consensus

12 analysts cover SNDX: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.91.

Common questions about SNDX

Where can I find SNDX SEC filings?: Rallies organizes SNDX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SNDX 10-K and 10-Q filings?: Rallies organizes SNDX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SNDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SNDX. It does not provide personalized investment advice.